Nasdaq or NYSE related Health Care sector Top Companies List by Market Cap as of August 2026
Nasdaq or NYSE listed Health Care sector Top Companies List by Market Cap as of August 2026. Nasdaq and NYSE related Health Care sector Largest Companies List by Market Cap as of August 2026
-
World Rank (Aug-2026)5,601Market Cap (Aug-2026)2.501 Billion USDWorld Rank (Jan-05-2024)7,887Market Cap (Jan-05-2024)1.157 Billion USDWorld Rank (Jul-30-2023)10,091Market Cap (Jul-30-2023)0.775 Billion USDWorld Rank (Dec-25-2022)7,533Market Cap (Dec-25-2022)1.200 Billion USDWorld Rank (Jan-07-2022)14,511Market Cap (Jan-07-2022)0.43 Billion USDAnnual Revenue in USD71 Million USDAnnual Net Income in USD-343 Million USDAnnual Results for Period EndingFor year ending December-2025Company Website
-
UFP Technologies
World Rank (Aug-2026)5,610Market Cap (Aug-2026)2.492 Billion USDWorld Rank (Jan-05-2024)7,568Market Cap (Jan-05-2024)1.243 Billion USDWorld Rank (Jul-30-2023)7,001Market Cap (Jul-30-2023)1.456 Billion USDWorld Rank (Dec-25-2022)9,077Market Cap (Dec-25-2022)0.876 Billion USDWorld Rank (Jan-07-2022)12,895Market Cap (Jan-07-2022)0.55 Billion USDAnnual Revenue in USD603 Million USDAnnual Net Income in USD68 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileUFP Technologies is primarily a medical designer and manufacturer company of custom devices, sub assemblies, components and packaging utilizing highly specialized foams, films and plastics. It is diversified in providing highly engineered products and components to customers in the aerospace, defense, automotive, consumer, electronics and industrial markets. The headquarters is in USA.Company WebsiteWikipedia -
BioCryst Pharmaceuticals
World Rank (Aug-2026)5,615Market Cap (Aug-2026)2.489 Billion USDWorld Rank (Jan-05-2024)7,310Market Cap (Jan-05-2024)1.323 Billion USDWorld Rank (Jul-30-2023)7,021Market Cap (Jul-30-2023)1.451 Billion USDWorld Rank (Dec-25-2022)5,228Market Cap (Dec-25-2022)2.135 Billion USDWorld Rank (Jan-07-2022)6,134Market Cap (Jan-07-2022)2.08 Billion USDAnnual Revenue in USD875 Million USDAnnual Net Income in USD264 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileBioCryst Pharmaceuticals is a Biotechnology company designs and develops small molecule medicines for rare diseases like hereditary angioedema (HAE) and fibrodysplasia ossificans progressive (FOP). The company annual revenue is 49 million USD and 140 employees as on 2019. The headquarters is in USA.Company WebsiteWikipedia -
Nektar Therapeutics
World Rank (Aug-2026)5,639Market Cap (Aug-2026)2.467 Billion USDWorld Rank (Jan-05-2024)21,027Market Cap (Jan-05-2024)0.108 Billion USDWorld Rank (Jul-30-2023)21,502Market Cap (Jul-30-2023)0.103 Billion USDWorld Rank (Dec-25-2022)13,797Market Cap (Dec-25-2022)0.404 Billion USDWorld Rank (Jan-07-2022)5,673Market Cap (Jan-07-2022)2.34 Billion USDAnnual Revenue in USD55 Million USDAnnual Net Income in USD-164 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileNektar Therapeutics is a research based development stage Biopharmaceutical company. It R&D pipeline of new investigational drugs includes treatments for cancer and auto immune disease and leverage Nektar's proprietary and proven chemistry platform in the discovery and design of new drug candidates. The headquarters is in USA.Company WebsiteWikipedia -
Pharvaris N.V.
World Rank (Aug-2026)5,661Market Cap (Aug-2026)2.448 Billion USDWorld Rank (Jan-05-2024)7,301Market Cap (Jan-05-2024)1.326 Billion USDWorld Rank (Jul-30-2023)11,900Market Cap (Jul-30-2023)0.573 Billion USDWorld Rank (Dec-25-2022)15,021Market Cap (Dec-25-2022)0.335 Billion USDWorld Rank (Jan-07-2022)11,928Market Cap (Jan-07-2022)0.64 Billion USDCompany ProfilePharvaris is a biotechnology sector company related clinical-stage company focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. Headquarters is in Netherlands.Company Website -
Clover Health Investments Corp.
World Rank (Aug-2026)5,665Market Cap (Aug-2026)2.443 Billion USDWorld Rank (Jan-05-2024)13,243Market Cap (Jan-05-2024)0.450 Billion USDWorld Rank (Jul-30-2023)12,458Market Cap (Jul-30-2023)0.524 Billion USDWorld Rank (Dec-25-2022)12,890Market Cap (Dec-25-2022)0.465 Billion USDWorld Rank (Jan-07-2022)7,414Market Cap (Jan-07-2022)1.50 Billion USDAnnual Revenue in USD1,924 Million USDAnnual Net Income in USD-86 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileClover Health Investments Corp is a Healthcare Technology and Insurance company. The headquarters is in USA.Company Website -
Bausch Health Companies
World Rank (Aug-2026)5,673Market Cap (Aug-2026)2.435 Billion USDWorld Rank (Jan-05-2024)4,383Market Cap (Jan-05-2024)2.995 Billion USDWorld Rank (Jul-30-2023)3,918Market Cap (Jul-30-2023)3.484 Billion USDWorld Rank (Dec-25-2022)4,972Market Cap (Dec-25-2022)2.291 Billion USDWorld Rank (Jan-07-2022)1,934Market Cap (Jan-07-2022)9.71 Billion USDAnnual Revenue in USD8,434 Million USDAnnual Net Income in USD-948 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileBausch Health Companies is a pharmaceutical company. It engages in the development, manufacture, market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over the counter products. The headquarters is in Canada.
Company WebsiteWikipedia -
Prestige Consumer Healthcare
World Rank (Aug-2026)5,675Market Cap (Aug-2026)2.434 Billion USDWorld Rank (Jan-05-2024)4,362Market Cap (Jan-05-2024)3.012 Billion USDWorld Rank (Jul-30-2023)4,138Market Cap (Jul-30-2023)3.219 Billion USDWorld Rank (Dec-25-2022)4,012Market Cap (Dec-25-2022)3.072 Billion USDWorld Rank (Jan-07-2022)4,829Market Cap (Jan-07-2022)3.02 Billion USDAnnual Revenue in USD1,089 Million USDAnnual Net Income in USD190 Million USDAnnual Results for Period EndingFor year ending March-2026Company ProfilePrestige Consumer Healthcare Manufactures and Distributes Quality in the over-the-counter Health Care and Household Cleaning Products to Retail Stores company. The company brands are digestive care, eye, ear, nose and throat, oral care, pain relief, pediatric care, skin care, sleep aids and women's health. The headquarters is in USA.
Company Website -
Amylyx Pharmaceuticals Inc.
World Rank (Aug-2026)5,709Market Cap (Aug-2026)2.410 Billion USDWorld Rank (Jan-05-2024)8,008Market Cap (Jan-05-2024)1.123 Billion USDWorld Rank (Jul-30-2023)6,840Market Cap (Jul-30-2023)1.514 Billion USDWorld Rank (Dec-25-2022)4,858Market Cap (Dec-25-2022)2.356 Billion USDWorld Rank (Jan-07-2022)8,733Annual Revenue in USD0 Million USDAnnual Net Income in USD-145 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileAmylyx Pharmaceuticals Inc is a pharmaceutical company that is dedicated to the development of potential therapies for neurodegenerative diseases. The headquarters is in United States.Company Website -
Urogen Pharma
World Rank (Aug-2026)5,781Market Cap (Aug-2026)2.357 Billion USDWorld Rank (Jan-05-2024)13,467Market Cap (Jan-05-2024)0.435 Billion USDWorld Rank (Jul-30-2023)12,378Market Cap (Jul-30-2023)0.530 Billion USDWorld Rank (Dec-25-2022)18,356Market Cap (Dec-25-2022)0.188 Billion USDWorld Rank (Jan-07-2022)18,931Market Cap (Jan-07-2022)0.20 Billion USDAnnual Revenue in USD110 Million USDAnnual Net Income in USD-153 Million USDAnnual Results for Period EndingFor year ending December-2025Company ProfileUroGen Pharma is a Biopharmaceutical company dedicated to building novel solutions that treat specialty cancers and urologic diseases. The company annual revenue is 3.5 million USD and 156 employees as on 2020. The headquarters is in USA.Company Website